Omalizumab Gets Tolerance in Patients With Severe Food Allergy: A Real-Life Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.827
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Term Effectiveness of Omalizumab Treatment in Thai Severe Asthmatic Patients: A Real-Life Experience

Asian Pacific Journal of Allergy and Immunology
MedicineAllergyImmunology
2017English

P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience

Thorax
PulmonaryRespiratory Medicine
2013English

Biomarkers and Outcomes in Omalizumab-Treated Patients With Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

IgE Testing Can Predict Food Allergy Status in Patients With Moderate-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria

Pediatrics
Child HealthPediatricsPerinatology
2017English

Quality of Life in Brazilian Children With Food Allergy

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Severe Atopic Dermatitis in Spain: A Real-Life Observational Study

Therapeutics and Clinical Risk Management
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy